Dyne Therapeutics Inc (DYN) — Cash Flow-to-Debt Ratio
Dyne Therapeutics Inc (DYN) has a Cash Flow-to-Debt Ratio of -0.67x as of March 2026, meaning its operating cash flow of $-144.92 Million could theoretically repay -1% of its total liabilities ($214.90 Million) in one year. Explore Dyne Therapeutics Inc (DYN) long-term investment share to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Dyne Therapeutics Inc Cash Flow-to-Debt Ratio (2007–2025)
Historical debt coverage capacity for Dyne Therapeutics Inc across 19 annual periods. Also explore Dyne Therapeutics Inc assets under control for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Dyne Therapeutics Inc (2007–2025)
Year-by-year debt coverage analysis for Dyne Therapeutics Inc. For market capitalisation and broader financial context, see Dyne Therapeutics Inc (DYN) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.88x | $-403.21 Million | $214.83 Million | ▲ +60.6% |
| 2024 | -4.76x | $-292.37 Million | $61.40 Million | ▼ -86.8% |
| 2023 | -2.55x | $-188.16 Million | $73.79 Million | ▲ +10.4% |
| 2022 | -2.85x | $-153.65 Million | $53.96 Million | ▼ -36.9% |
| 2021 | -2.08x | $-119.56 Million | $57.47 Million | ▲ +50.9% |
| 2020 | -4.24x | $-46.51 Million | $10.97 Million | ▲ +14.0% |
| 2019 | -4.93x | $-11.83 Million | $2.40 Million | ▼ -1456.8% |
| 2018 | -0.32x | $-4.16 Million | $13.15 Million | ▼ -634.4% |
| 2017 | 0.06x | $585.00 Million | $9.87 Billion | ▼ -3.5% |
| 2016 | 0.06x | $676.00 Million | $11.01 Billion | ▲ +462.9% |
| 2015 | 0.01x | $94.00 Million | $8.62 Billion | ▲ +244.4% |
| 2014 | -0.01x | $-62.00 Million | $8.21 Billion | ▼ -113.3% |
| 2013 | 0.06x | $175.00 Million | $3.08 Billion | ▲ +362.3% |
| 2012 | -0.02x | $-44.00 Million | $2.03 Billion | ▼ -226.4% |
| 2011 | -0.01x | $-20.00 Million | $3.02 Billion | ▼ -111.4% |
| 2010 | 0.06x | $423.00 Million | $7.27 Billion | ▲ +243.8% |
| 2009 | 0.02x | $135.00 Million | $7.97 Billion | ▼ -48.4% |
| 2008 | 0.03x | $319.00 Million | $9.73 Billion | ▼ -16.4% |
| 2007 | 0.04x | $341.00 Million | $8.69 Billion | — |